Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 2
2019 1
2020 1
2021 1
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Pérez JMT, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Pérez JMT, et al. Among authors: mesia nin r. Rev Esp Patol. 2023 Jan-Mar;56(1):45-57. doi: 10.1016/j.patol.2022.06.003. Epub 2022 Aug 27. Rev Esp Patol. 2023. PMID: 36599600 Review.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Contouring aid tools in radiotherapy. Smoothing: the false friend.
Marruecos Querol J, Jurado-Bruggeman D, Lopez-Vidal A, Mesía Nin R, Rubió-Casadevall J, Buxó M, Eraso Urien A. Marruecos Querol J, et al. Among authors: mesia nin r. Clin Transl Oncol. 2024 Mar 17. doi: 10.1007/s12094-024-03420-9. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38493446
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Trigo J, et al. Among authors: mesia nin r. Clin Transl Oncol. 2022 Oct;24(10):1890-1902. doi: 10.1007/s12094-022-02856-1. Epub 2022 Jun 23. Clin Transl Oncol. 2022. PMID: 35739348 Free PMC article.
Is ranitidine necessary as premedication for regimens containing paclitaxel? A non-inferiority study.
Montero Pérez O, Martinez Benavides J, González Fernandez T, Guerra Prio S, Romero Domínguez R, Mesía Nin R, Clopés Estela A. Montero Pérez O, et al. Among authors: mesia nin r. Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(9):877-883. doi: 10.1080/17512433.2023.2238596. Epub 2023 Jul 21. Expert Rev Clin Pharmacol. 2023. PMID: 37477611 Clinical Trial.
SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma.
Pastor Borgoñón M, Mesía Nin R, Cruz Hernández JJ, Isla Casado D; SEOM (Spanish Society for Medical Oncology). Pastor Borgoñón M, et al. Among authors: mesia nin r. Clin Transl Oncol. 2010 Nov;12(11):749-52. doi: 10.1007/s12094-010-0590-9. Clin Transl Oncol. 2010. PMID: 20974567
Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study.
Martínez-Trufero J, Lozano Borbalas A, Pajares Bernad I, Taberna Sanz M, Ortega Izquierdo E, Cirauqui Cirauqui B, Rubió-Casadevall J, Plana Serrahima M, Ponce Ortega JM, Planas Toledano I, Caballero J, Marruecos Querol J, Iglesias Docampo L, Lambea Sorrosal J, Adansa JC, Mesía Nin R; Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC). Martínez-Trufero J, et al. Among authors: mesia nin r. Clin Transl Oncol. 2021 Aug;23(8):1666-1677. doi: 10.1007/s12094-021-02567-z. Epub 2021 Apr 19. Clin Transl Oncol. 2021. PMID: 33876416 Clinical Trial.
Correction to: Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M. Trigo J, et al. Among authors: mesia nin r. Clin Transl Oncol. 2023 Jan;25(1):292. doi: 10.1007/s12094-022-02954-0. Clin Transl Oncol. 2023. PMID: 36152138 Free PMC article. No abstract available.
SEOM clinical guidelines for the treatment of head and neck cancer.
Mesía Nin R, Pastor Borgoñón M, Cruz Hernández JJ, Isla Casado D; SEOM (Spanish Society for Medical Oncology). Mesía Nin R, et al. Clin Transl Oncol. 2010 Nov;12(11):742-8. doi: 10.1007/s12094-010-0589-2. Clin Transl Oncol. 2010. PMID: 20974566
11 results